Longwood Capital Partners »

4d Molecular Therapeutics In shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of 4d Molecular Therapeutics In shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3M 242k 9.31

More positions owned by Longwood Capital Partners

Ideaya Biosciences Call Call Option (IDYA)
Praxis Precision Medicines I Com New (PRAX)
Terns Pharmaceuticals (TERN)
Aadi Bioscience (WHWK)
Tango Therapeutics (TNGX)
Bright Minds Biosciences Com New (DRUG)
Sutro Biopharma (STRO)
Erasca (ERAS)
Surrozen Com New (SRZN)
Ocular Therapeutix (OCUL)
Compass Therapeutics (CMPX)
Minerva Neurosciences Com New (NERV)
Moonlake Immunotherapeutics Class Ord A (MLTX)
Argen Se - Sponsored Adr (ARGX)
Oculis Holding Ordinary Shares (OCS)

View all positions for Longwood Capital Partners

Top funds holding 4d Molecular Therapeutics In

Longwood Capital Partners
Caitong International Asset Management

View all funds holding 4d Molecular Therapeutics In